SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " Bottom Line " 119 found 🔀 AI-powered Shuffle
Heartland Small Businesses Match the Nation on AI Adoption as Owners Say AI Boosts Their Bottom Line
/PRNewswire/ -- Heartland Forward, a non-profit think-and-do tank accelerating economic growth across the heartland, today released a new survey titled "AI on...
When “DEI” research is cut, what happens to community health?
“I’m just going to run to the grocery store!” How many times have we said this without thinking about it? For most of us, it's usually an easy walk or a short drive to get the cheese we forgot. In reality, though, 13% of the U.S. population (about 39 million people) live in “food deserts,” which means living more than a mile from a grocery store in urban areas and more than 10 miles in rural areas. This was the case for people in Pittsburgh’s Hill District, where a quick run to buy food wasn’t an option. In the 1930s, federal maps marked the Hill as "hazardous" for lending, a practice known as redlining that steered investment away from Black neighborhoods. Decades of disinvestment followed, and residents went about 30 years without a nearby grocery store. This made it hard to keep healthy eating habits and contributed to chronic disease. When a grocery store finally opened in the area in 2013, researchers saw the opportunity and launched the PHRESH study, which initially compared the health of participants from the Hill district to those in the Homewood district. Over time, the study expanded to other factors such as brain health and Alzheimer's risk. Residents like Roderick Blair overcame initial hesitation to share their health data, trusting it would benefit their neighborhood. Then, in August 2026, the NIH abruptly canceled the study’s grant, citing that it was “subjective” and fell outside their scientific scope—an effect of the administration’s interpretation of diversity, equity and inclusion (DEI). Research like PHRESH can help determine what changes in a neighborhood actually improve health, so cutting it has left that question unanswered. Other canceled studies have examined health issues like maternal health, preterm birth rates, or sickle cell disease. Courts have reversed some of these grant cancellations, but not all of them. If we really want America to be healthier, research into why some communities get sicker than others is absolutely critical. The law that created the federal minority health research institute passed with bipartisan support in 2000. But these days, as evidenced by grant cancellations, the political shift in attitudes toward DEI means we often lose access to the health information we need to help all communities thrive. DEI vs. health equity vs. equality and the overlap (or lack thereof) The letters “DEI” evoke very different reactions depending on who you are in the U.S. DEI programs can address gender, disability, age, and other factors, but the fiercest debate centers on race. For some people, hearing DEI brings to mind policies that may have cost them a job or a college seat because they are white. Others see DEI as a matter of justice: a way to expand representation and opportunity for groups that have been historically marginalized. Both perspectives are rooted in lived experience, and both center on the same question: whether hiring and admissions practices are fair. Hiring and admission practices, though related, are not the same as health equity. Health equity is “the attainment of the highest level of health for all people.” It’s the recognition that some groups of people consistently experience worse health outcomes than others. For instance, black mothers die from pregnancy-related complications at three times the rate of white mothers, and rural Americans are more likely to die from issues such as heart disease and cancer. Equity is also often conflated with “equality,” which leads to misunderstanding of how to actually best support communities. Equality ignores the fact that we aren’t all starting life with the same resources or circumstances, whereas equity is about helping people get what they specifically need based on their situation so they have the chance to achieve the same outcome as anyone else. For example, if every household in Pittsburgh got a $30 grocery gift card, that would be equal. But during the decades the Hill District went without a grocery store, that card wouldn’t have helped much. Equity means making sure everyone can actually access a store in the first place. DEI policies can overlap with health equity in many ways. For example, they may help expand access to quality education and stable, well-paying jobs, which in turn can provide health insurance, safer housing, and improved finances—all of which can reduce health disparities. But to make that happen, we first need data to identify disparities in communities and to develop solutions that effectively address them. What we lose when the research stops Community data is important to health equity because: You can’t fix what you don’t see: Data show which communities are most affected by health factors such as infection, heart disease, and cancer. If we don’t know what is happening and where, then we can’t develop interventions to help. Poor health costs everyone: Chronic disease is expensive—both to the individual person and to the overall economy. Understanding what groups of people are most at risk allows us to develop interventions that can save everyone money. Disparities exist for many communities: Health equity includes disparities that exist due to a whole host of factors, such as family background, race and ethnicity, rural vs. suburban residence, gender and sexual orientation, veteran status, disability, and lower income. This means many Americans can benefit from research into differences in health outcomes and how to improve them. Trust is easy to lose: Some participants in the PHRESH study were initially vocal about their concerns about participating. But that trust was earned because the researchers kept their promises and centered their work on the community. When projects are canceled mid-cycle, researchers have no choice but to leave behind communities they had promised to help. This hurts trust in the long run. It’s also a very inefficient use of resources, and it will take significant time and effort to redo the work when the government realizes this work is important again. How should we talk about health equity? This is hard because the words “equity” and “DEI” are currently very politically charged. So whether you’re a public health professional, teacher, or friend, how we talk about this topic matters. The right framing can help people who might otherwise be skeptical see why health equity research is important and deserves funding. Here are some suggestions to help your conversations: Choose your words strategically: Who are you trying to reach with your message? Are they likely to be resistant to terms like “diversity” and “equity”? If so, find alternative words to use to still get the message across. It is frustrating to be in that position, but the goal of improving health is too important not to try to make inroads. Sometimes simply reframing can help the message reach those who need to hear it. Focus on the problem: The terms “health equity” and “DEI” are abstract. Make it more specific. For example, discuss differences in maternal death or ways to improve health outcomes in rural communities. These still have equity at their core but will likely be better understood by those you’re talking with. Focus on systems: Disparities exist, but if they are communicated poorly, people can mistakenly think the issue is the individual’s fault. Disparities are largely driven by failures of the system—such as lack of access to health care and a long legacy of racism. When discussing the disparities, frame them around these systemic issues to ensure blame isn’t placed on the individuals impacted. Tell stories: Personalize these policies by using stories from those impacted that connect to the data you’re trying to convey. This helps make the policies and outcomes more concrete and meaningful. Bottom line Some communities end up sicker than others. That’s just the facts. We can argue about the best way to do that research, but canceling it simply because it may be linked to DEI doesn’t make anyone healthier. It just leaves communities like the Hill district behind. And in the end, it causes us all to move backward in our efforts to improve health in this country. Love, EM Big thanks to MacKenzie Isaac & Legairre Radden, who reviewed this piece and generously shared their expertise and lived experience to help improve it. Dr. Liz Marnik, PhD, is Executive Director of The Evidence Collective and a science communicator and immunologist working at the intersection of public trust, science, and public health. To discuss communication training on topics like health equity and storytelling, email Liz at liz@yle.health or learn more on our website. Your Local Epidemiologist (YLE) comprises a team of experts, ranging from physicians to immunologists to epidemiologists to nutritionists, working together with one goal: to “translate” ever-evolving public health science so that people are well-equipped to make evidence-based decisions. The YLE suite of newsletters reaches over 475,000 people across more than 132 countries. This newsletter is free to everyone, thanks to the generous support of fellow YLE community members. To support the effort, subscribe or upgrade below: Your Local Epidemiologist is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe
Riders see improvements, businesses struggle as Maryland Parkway construction stretches on
While some RTC riders say service has improved, local business owners say the ongoing construction is still hurting their bottom line.
Rochester’s explosive growth leaves some businesses behind
A public-private partnership that guides Mayo Clinic’s expansion approved half a million dollars amid ongoing construction that business owners say is hurting customer access and their bottom lines.
Owner says fencing outside longtime Greektown liquor store hurts business, sues
Athens Liquor owner Ather Butris claims street festival fencing has become a barrier to his bottom line, prompting a lawsuit against the Greektown Neighborhood Partnership.
Small business lending is alive and well, SBA administrator says
Small Business Administration administrator Kelly Loeffler discusses concerns over artificial intelligence on 'The Bottom Line.'
As pharmacies across Vermont close, North Star Health opens 3 new ones
The pharmacies take advantage of the health center’s federal designation that allows them to pay less for drugs, charge patients lower costs and still meet their bottom line.
Minnesota farm-to-table business faces higher costs as fuel prices rise
A farm-to-table business owner says rising fuel prices are negatively impacting her bottom line. Traci Walkowski sells produce and pasture raises turkeys and chickens in Hutchinson, Minnesota and tells Brownfield traveling to farmers markets is getting more expensive. “Obviously we don’t see the impact as much as someone who’s using gallons of diesel to you […]
Tourism task force closes in on draft of management strategy
“The bottom line is tourism’s here to stay, and the residents are here to stay,” said J.E. Austin’s president, Joe Lowther, who led the discussion in person at the meeting.
Academy Sports (ASO) Turns A Tariff Refund Into A Profit Surge
On September 10, Academy Sports and Outdoors (NASDAQ:ASO) posted second quarter results that looked strong on the bottom line and shaky underneath it. Net sales rose 3% to $1.65 billion, but comparable sales slipped 0.4%, and the gap between those two numbers is where the real story sits. A one-time tariff refund did most of […]
Drink up: Centreville raises a glass to successful community, business engagement events
CENTREVILLE — A bigger win than the bottom line, Economic Development Manager Gaye Adams said the recent Sip and Savor Trail and Maryland Crafted: Centreville event success lies deeper than
This shows how ‘serious' the Trump administration is about winning the midterms: Political analyst
Fox News political analyst Gianno Caldwell discusses the GOP's strategy for the midterm elections and voter turnout efforts on ‘The Bottom Line.’
Business owners near the University of Cincinnati push back on street closures meant to curb violence
Business owners in Cincinnati’s CUF neighborhood near the University of Cincinnati say evening street closures put in place following a series of shootings are hurting their bottom lines.
Orlando-area Week 4 high school football scoreboard
Here is the schedule and scoreboard for Week 4 games for Orlando area high school football teams. Home teams are on the bottom line. Rankings are from the Sentinel Super 16. Check back often, as scores will be updated as games progress. Super 16 Coaches Poll: DeLand football returns to unanimous No. 1 status Varsity content editor Buddy Collings can be contacted by email at ...
North Carolina business owner says sales have bounced back after Hurricane Helene
Panelists Brittany Brady and Joe Dinan discuss how North Carolina is economically recovering and rebuilding two years after Hurricane Helene on ‘The Bottom Line.’
Archrock’s (AROC) Compression Business Locks In Years Of Growth
On August 4, Archrock (NYSE:AROC) posted second-quarter results that told two different stories at once. Revenue slipped to $371.2 million from $383.2 million a year earlier, yet net income climbed to $66.7 million, and earnings per share rose to $0.38. That gap between a shrinking top line and a growing bottom line is the puzzle […]
Rising energy, fuel costs cut into bottom line for Pa. businesses
According to an August poll, 57% of residents reported it was very or somewhat difficult to afford monthly utility costs.
Rising energy, fuel costs cut into bottom line for Pa. businesses
At Shirley’s Cookie Company, Facilities Maintenance Manager Richard Weyant detailed the efforts he’d overseen to keep utility costs down at their Blair County facility. They included thousands of dollars invested to upgrade to LED lighting alongside new and more efficient HVAC systems. While electricity use went down by 5.7% over four years, he told Republican […]
The WNBA needs to look at this from a business perspective: Maine Girl Dads founder
Maine Girl Dads founder Leyland Streiff discusses the 'Support Sophie' movement on 'The Bottom Line.'
Restaurants inside Freedom 250 race zone say they’re seeing less business
Some D.C. restaurants around the security zone for the Freedom 250 Grand Prix say closures near the race course is hurting their bottom line, while students at a nearby school were forced to learn remotely on Friday.
ICYMI: Sen. Banks Joins the Bottom Line on Fox Business Network
WASHINGTON, D.C. – Last night, Senator Jim Banks (R-Ind.) joined The Bottom Line on Fox Business Network to discuss the Senate’s priorities ahead of the August recess, the AI race, and how AI is reshaping government and the workforce. Click the image above for the full discussion. Key Excerpts on Senate priorities: Sen. Jim Banks (R-Ind.): “We have a full […]
Northeast Minnesota wildfires causing disastrous economic impacts to tourism industry
Small business owners in northeastern Minnesota told their state legislators Friday that the wildfires that have been burning in and around the Boundary Waters for almost a month have had a “disastrous” impact on their bottom lines. One canoe outfitter says he lost 98 percent of his revenue to cancellations in July.
The Streaming Bubble Keeps Popping
(Welcome to the Entertainment Strategy Guy, a newsletter on the entertainment industry and business strategy. I write a weekly Streaming Ratings Report and a bi-weekly strategy column, along with occasional deep dives into other topics, like today’s article. Please subscribe.) One of my rules is “never bet against PE [private equity]”. This isn’t to say that I agree with their methods or tactics or strategies or financial innovations (aka shenanigans). Just that in the long arc of financial history, they’ve tended to return very good returns to their shareholders. That said, their forays into entertainment have left me...skeptical. I’ve written before about PE’s production company/celebrity production company roll ups, and those haven’t really worked out. Some PE groups tried to “roll up” an industry that isn’t “roll-up-able” for lack of a better term—since the barrier to entry for starting a production company is very low—often paying top dollar for celebrity production companies at the height of streaming valuations. So yeah maybe we can bet against PE when they venture into filmed entertainment. I’ve also noted that studio lots seemed to be a bubble back in 2022. Sure enough… Yikes! That sure sounds like some private equity guys lost some money. The only caveat being that holding a lot of land in Los Angeles is always valuable. But that wasn’t the pitch and likely real estate investment companies overpaid for said land. I mean, Goldman Sachs had to repossess it after all. (Technically, I’m not sure these buyers were traditional private equity, but PE was buying LA studio lots earlier this decade.) All to say: I call out bubbles when I see them, and they often pop. Anywho, my most famous bubble call was the “streaming bubble”, specifically that the major streamers were making too many shows and films. And that it could all come crashing down. Notably, I made this call before the strikes of 2023, but those strikes potentially accelerated the popping. And now it has indeed popped. One of my most popular articles of last year made that exact case. A year later, it’s time to update that analysis. The bottom line is that the streaming contraction continues. Credit where credit is due, Luminate—an analytics company whose data I use weekly in my streaming ratings report—called this out in a recent report I saw highlighted in both Bloomberg and The Hollywood Reporter. But I’m adding my data to their look, including streaming films and kids TV shows. I’ll also provide some other data that all tells the same picture. Let’s dive in! Subscribe The Number of Streaming TV Shows, Films and Specials Is Declining AGAIN in 2026 Let’s get right to the data, starting with my dataset. Specifically, each week I track every “notable” title to come out on streaming. I try to grab every title on every major streamer, meaning if it’s a first run or original or exclusive, I track it. This helps me call out the “dogs not barking” and the misses/flops each week. So that will be our first series of charts, my weekly collection data. Let’s start with the raw TV show, film and special data, by week. Note: As the years have gone by, I have actually added more sources (going from just one source to five sources) to find new titles, meaning that this data collection is, likely, more accurate now than in the past. Which means my team and I are more likely to have undercounted titles in the past rather than today. I like to cut the data several different ways. Here’s that same look, by quarter, to more sharply show the trends: And here’s the data just looking at the first half of each year. That’s the same data, just cut three different ways with three different time periods. Note that films, TV shows, and specials are all down by 25%, 42% and 17%, respectively, from 2022. The good news is that the number of films and specials actually increased year-over-year from 2025 to 2026, but not enough to offset the 25% decline in TV shows. Now, I also look at kids shows, and here they are pulled out on their own: And here’s that by quarter: This really seems to be a notable area of pullback by the streamers. Kids shows are down 80% from 2022. This reflects some formerly Disney+ shows going to cable TV first, but also pullbacks from HBO Max, Prime Video and Netflix. I also categorize the TV shows by English language and non-English language, and that also reveals a lot of where the drop comes from: And here is by the half-year: In this look, the good news is the drop for English language shows seems to have stabilized in the last year. But the bad news is the long term decline from the 2022 peak. Other Data So I wasn’t the only person to notice this decline in the number of shows. I have a few other data sources for this, though most only go through the end of 2025. As I said, Luminate beat me to the punch, so let’s look at their data. We’re just getting started with this issue, but the rest is for paid subscribers of the Entertainment Strategy Guy, so if you’d like to find out… What TV loss streaming didn’t make up for... How Netflix has changed their programming slate over time… Ten more images charting the decline of production... What type of films aren’t being made anymore... The good news (for movie theaters)… And more... ...please subscribe! We can only keep doing this great work with your support.
Does public health *need* MAHA?
Last week, our friend Dr. Craig Spencer sparked an ongoing volatile discussion with his Atlantic article “Public Health Needs MAHA.” Some have come out in strong dissent, others are cheering, and others are simply lamenting that we find ourselves in such a divided world to begin with. We will dare to dip our toes in these controversial waters, too. Does public health need MAHA? We think in some ways yes, and in other ways, no. MAHA leaders versus the everyday MAHA supporter The vitriol in this debate mostly comes from one collapsed distinction: the leadership of MAHA is not necessarily the same as the people who support it. Say “MAHA” and most people picture RFK Jr. Fair enough, as he coined the term and holds most of the power. And, yes, some MAHA followers treat Kennedy as something close to a saint. But talk to the grassroots, and it’s not a monolith. They’re Republicans, Democrats, and Independents. People who distrust vaccines and vaccine supporters. It’s a wide, eclectic coalition. The data backs this too: 4 in 10 Americans support the movement—that’s a lot of people! But according to polls, vaccines and medical choice (the issues most tied to Kennedy personally) are cited by only 4% as their reason for supporting the movement. For many, the motivations are much broader. Many MAHA supporters are signing up for the idea that “something needs to change” with health in this country. They’re asking good-faith questions about corporate influence on our health systems, health care costs, nutrition, chemicals, and clean air and water. These are all questions that plenty of public health professionals recognize as legitimate and also care about very deeply. Blurring the lines between the leadership and grassroots does real damage in two important ways: It hands the 4 in 10 exactly the narrative already fed—that the health ecosystem doesn’t listen, doesn’t care, and paints every critic with the same brush. It gives the actual bad actor more power. RFK Jr. has done irreparable damage and can’t be trusted. What the MAHA movement gets right A healthy population is something the public health field was literally built on, and many of these topics are things we have dedicated our lives to. Yet the MAHA movement has captivated nearly half the country in a way the public health establishment has failed to achieve. So that means MAHA is doing something right. Some of it may be timing (after a Covid-19 pandemic and deep frustration and mistrust with institutions). The movement also does three other things really well: 1. It gives a new, louder voice to system failures. While MAHA is not a monolith, one theme stays consistent across their stories: the system failed them. For some, it was the system that flooded their communities with opioids and then walked away. For others, it was the system that let their business collapse during Covid with no safety net in sight. For others still, it was the system that failed to help them manage a complex chronic illness, bouncing them from physician to physician without any real answers. And in many ways, our health ecosystems are failing Americans. Why are medical bills so incomprehensible? Why do some kids get a healthy school lunch and others don’t? Why do an epidemiologist and a MD/PhD student have to start newsletters in the middle of the biggest public health emergency in a century, just so people can get straight information? Because the systems failed. This deep-seated frustration driving many Americans to search for solutions elsewhere needs to be recognized. 2. MAHA has brilliant comms central to their efforts. MAHA figured out something most health institutions still have not: the information landscape changed. It’s participatory now, not top-down; influence runs through many nodes in a community, not one institution; and storytelling and telling audiences “what you really think” moves people more than data dumps do. MAHA goes where audiences are listening, using podcasts, social media, and memes in ways most health institutions would scoff at—but it works. 3. They are very good at organizing. A MAHA meeting feels like a rally: energy, speakers, music, and most importantly, an action for everyone. Someone’s writing the next policy brief, someone’s seeding a narrative, someone knows the next legislative deadline, someone’s sending the text messages for a campaign. None of this is new (ask the civil rights movement), but MAHA knows it works and has capitalized on it. What MAHA gets wrong This list could be much longer, and this newsletter has spent a lot of time covering it, but here are a few things: Poor use of scientific evidence. This is the fundamental problem with many MAHA policies: the hype outpaces the science, and experts are often villainized for pointing this out. MAHA leadership has traded real solutions for cheap wins. For example, instead of taking on the powerful food industry and passing real reforms, it has celebrated french fries made of beef tallow and taken out artificial dyes from still very sugary children’s cereal. These changes won’t move the needle on America’s diet. MAHA leadership has tried to dismantle vaccine access in the U.S. While many MAHA supporters emphasize other issues, the effort to change vaccine policy has become MAHA’s signature effort. This is not surprising given RFK Jr.’s extensive track record campaigning against vaccines. It has rallied behind the wrong leader. RFK Jr. has a decades-long track record of villifying doctors, scientists, and public health workers, well before he became HHS secretary. He is known for his decades-long work sowing distrust in vaccines as well as life-saving treatments like antiretroviral therapy for HIV. This is not a serious person who can move the needle on health in the U.S, and he has already done serious damage. Public health needs more than defense Defending the evidence is absolutely necessary so health in the U.S. doesn’t move further backward. The public health establishment is very good at defense. The problem is this defense often sounds like defending the status quo, which has failed many people. Public health needs to offer an alternative to RFK Jr.’s MAHA—one that is rooted in evidence, truly listens to and addresses people’s frustrations, and has innovative solutions and the courage to change the systems. How do we get there? Find common ground. Do you know what most people care most about? The abysmal cost of healthcare. Start there. Fight for the human loudly. Too often, communications and engagement center on science with a capital S, funding mechanisms, or the CDC/FDA/NIH. Not the person. So the public doesn’t see themselves in it. Instead, they see people fighting for the very powerful systems that they feel negatively impact their health and well-being. Let the public feel and hear that you see their frustrations, you get it, and you’re fighting for them within the system. Recognize when pro-science messages are alienating people. Facts absolutely matter, but angrily venting only alienates people further. Our friend Elisabeth Marnik recently wrote a New York Times article about her experience growing up unvaccinated and how listening and empathetic conversation are the only ways to reach people that really work (a position backed by communication science). Her comments section was full of hateful comments from pro-vaccine individuals attacking her for daring to suggest we approach vaccine-hesitant individuals with empathy. It is possible to both stand firm behind scientific evidence and empathize with people who don’t trust it. Lean into politics smartly. Often, public health has shied away from politics: Don’t touch it, lest you get burned. But this fails to recognize that the third rail is what fuels the train: who is elected determines our budgets, our priorities, and our authority. Being political means being very savvy in strategy on both sides of the aisle, knowing your audience, and recognizing that political capital is as scarce as financial resources and needs to be allocated accordingly. Bottom line So does public health need MAHA? That’s not really the right question. Public health has a responsibility not to dismiss 40% of the country who feel heard by this movement and are frustrated that the system has failed them. And it has a responsibility to stick to the evidence and recognize MAHA leadership for what it is: a danger to our nation’s health. Both can, and should, be done. Love, YLE and KP A big thanks to Craig Spencer, who had the courage to put his neck out there to start a much-needed discussion at such a critical moment—one that is determining the identity of an entire field. Kristen Panthagani, MD, PhD is completing an emergency medicine residency and research fellowship focusing on health literacy and communication. In her free time, she writes the newsletters You Can Know Things debunking health myths and rumors and The Public Health Roundup. Views expressed belong to KP, not her employer. Your Local Epidemiologist (YLE) comprises a team of experts, ranging from physicians to immunologists to epidemiologists to nutritionists, working together with one goal: to “translate” ever-evolving public health science so that people are well-equipped to make evidence-based decisions. The YLE suite of newsletters reaches over 475,000 people across more than 132 countries. This newsletter is free to everyone, thanks to the generous support of fellow YLE community members. To support the effort, subscribe or upgrade below: Subscribe
What Mamdani is doing with city-run stores is illegal and irresponsible, small business owner says
Multicultural Business Coalition Chairman Frank Garcia says the mayor did not want to meet with his group over concerns about the city-run grocery store project on ‘The Bottom Line.’
The new "science golden age" looks suspiciously like a grift
This edition of PN is made possible by paid subscribers. Become one ⬇️ 🚀 Subscribe to PN 🚀 The Trump regime is trying to usher in a “Golden Age in Science” where scientific research is run like a Trump family business, artificial intelligence is all that matters, profit is everything, and expertise is for chumps. Or at least that’s the vision emerging from a new 123-page “Report to the President” from Michael Kratsios, the Director of the White House Office of Science and Technology Policy. In a normal administration, you could probably skip over learning about a science policy document — but this is no normal administration, and this is no normal science policy document. Instead, it’s Trump’s attempt to end the actual golden age of science that was kicked off in 1945 with the publication of '“The Endless Frontier” by Vannevar Bush. [ ](https://www.publicnotice.co/p/harmeet-dhillon-portland) [ Harmeet Dhillon demonstrates danger of posting through it ](https://www.publicnotice.co/p/harmeet-dhillon-portland) Liz Dye · Jul 29 [ Read full story ](https://www.publicnotice.co/p/harmeet-dhillon-portland) Bush, at President Franklin Delano Roosevelt’s request, laid out a vision of federal support for science that centered on funding universities to do basic research, saying that as long as those institutions were “vigorous and healthy and their scientists are free to pursue the truth wherever it may lead, there will be a flow of new scientific knowledge to those who can apply it to practical problems in Government, in industry, or elsewhere.” Kratsios’s report is supposed to be the successor to Bush’s, and even apes the format, but this isn’t really a document about science policy. It’s one about ending science research as we know it in favor of shoveling cash at big tech companies. While it might be temping to wave this away as an aspirational policy document, Trump has already begun to shift billions in research funds to AI projects and has taken a hatchet to science funding across the board. He’s teed up the shift Kratsios proposes here, and since neither Congress nor the Supreme Court seem inclined to stop him from doing whatever he wants with taxpayer money, it isn’t doomering or hyperbole to say we are staring down the barrel of a world where the only “science” the government intends to support is for-profit tech and defense advancements. Science for dummies Part of how you can tell this isn’t a document about science is that you are immediately faced with an absolute wall of business-speak of the worst sort. Did you know we must “tightly couple our science and technology enterprises to ensure that groundbreaking ideas invented in the United States are rapidly prototyped, tested, manufactured, and scaled domestically”? You do now! That tone isn’t surprising, because Kratsios has no background in science or research. He has a bachelor’s in political science and spent most of his career working for Peter Thiel at Thiel Capital. After a stint in the first Trump administration as Chief Technology Officer, where he also did not do any science, Kratsios was tasked in 2020 with overseeing the Pentagon’s research budget for a brief time, a position that, as the Wall Street Journal put it, “carries a great deal of power in terms of dictating investment allocations.” He spent the Biden years at Scale AI as “head of strategy,” which you will also note is neither a science nor a research job. But Scale AI has contracts with the Department of Defense and, as the Washington Post wrote in 2023, “has been aggressively pitching itself as the company that will help the US military in its existential battle with China.” And now you have the necessary background for our new golden age, which is going to be a golden age of taking money away from scientists and universities and giving it to companies like Scale AI. A note from Aaron: Working with brilliant contributors like Lisa takes resources. If you aren’t already a paid subscriber, please become one to support our work. 👇 Subscribe In a genuinely galling move, Katsios spends a lot of time slamming universities because of “administrative burdens on researchers” and the “well-documented inefficiencies” in academia, the message being that those damn universities waste the time of amazing researchers with paperwork. Except it’s the administration that is attempting to impose inefficient, unnecessary burdens on those researchers with a proposed Office of Management and Budget rule that would require senior political appointees to approve every science grant and ensure it aligns with Trump’s personal priorities. Researchers would also have to seek prior government approval to attend conferences or publicize their research. And political appointees could terminate any grant at any time if they feel like it. [ ](https://www.publicnotice.co/p/omb-rule-science-funding) [ The murder of expertise ](https://www.publicnotice.co/p/omb-rule-science-funding) Lisa Needham · Jun 11 [ Read full story ](https://www.publicnotice.co/p/omb-rule-science-funding) But when it comes to AI, we’re going to “restore permissionless innovation.” The report proposes to give lucky ducky innovators a pile of cash up front for grants lasting five years or longer, saying “awards should be fully-funded in year one, with all resources earmarked upfront, to minimize administrative burdens and reduce pressure for researchers to generate intermediate results to secure continued funding.” Yeah, wouldn’t want to have to make the Very Special Tech Bros show results or get money parceled out year by year like the plebes at universities. The report also proposes that we should have “fast grants” with “simplified applications requiring just a few pages of writing” because that is definitely how science works, just writing a bit off the dome and getting some cash. [ ](https://www.publicnotice.co/p/trump-ai-action-plan-altman-llms) [ Tech elites are turning AI into ChatGPTrump ](https://www.publicnotice.co/p/trump-ai-action-plan-altman-llms) Paul Waldman · July 29, 2025 [ Read full story ](https://www.publicnotice.co/p/trump-ai-action-plan-altman-llms) Oh, and we should have prizes and challenges, where multiple teams compete. The proposed prizes include incentives like “advance procurement commitments,” which means the federal government agrees to buy whatever is being developed. There’s also “regulatory fast-tracking,” making sure all those great AI thingies don’t have to wait too long to be unleashed on a market. These aren’t incentives to do science. These are incentives to develop things with tax dollars that you can then sell to the government for more tax dollars. In the suggestion that might be the most unhinged, the most very opposite of how both government and research work, our new age will include “golden tickets.” That’s where an individual reviewer in an agency — yes, just one person — can “recommend unconventional proposals that may not pass consensus-driven review panels” because somehow this will “surface valuable ideas too divisive for committees and attract higher quality reviewers by empowering them to exercise independent scientific judgment.” Yes, that’s saying that a random person in an agency should be able to shovel money at some idea even if it can’t pass a review panel, and that the opportunity to do so will attract better employees because apparently all the best minds in science are chomping at the bit to be allowed to unilaterally fund AI research based on their personal vibes. But that isn’t at all how actual science works, and actual scientists aren’t unhappy about review panels. They work collaboratively, not siloed in some secret race to create the next AI chatbot. A 2020 study by the National Bureau of Economic Research examined whether peer review panels succeed in helping agencies predict which research ideas will best advance science. Peer review was better at finding “diamond in the rough” applicants than a single government program official. How about that. Trump always wants a taste It’s painfully clear that what Katsios is trying to do here is turn the whole of government science research and funding into the sort of “move fast and break things” paradigm that is the hallmark of big tech. That method works to line the pockets of tech executives, but it isn’t science. There’s a reason the government funds different kinds of research than private tech companies do. What Katsios either fails to understand or deliberately ignores is that the federal government is the main funder of basic research precisely because it can take a long time for it to bear fruit and is not intended to be profitable as such. “Basic” here does not mean rudimentary or simple, but rather research that is designed to advance scientific knowledge instead of achieving a specific outcome or product. Big tech companies don’t widely fund that sort of research, because it doesn’t make them money. Industry dollars account for only about 20 percent of basic research funding, while the government contributes around 60 percent. Big tech companies and startups do, however, rely on and benefit from that basic research. A 2019 study found that 35 percent of all patents obtained by venture-backed startups from 1976 to 2016 cited federally supported research. Basic research funded by the NIH contributed to every single drug the FDA approved from 2010 to 2016. [ ](https://www.publicnotice.co/p/trump-saudi-nuclear-deal) [ The Saudi nuclear farce and governance by whim and meme ](https://www.publicnotice.co/p/trump-saudi-nuclear-deal) Noah Berlatsky · Jul 27 [ Read full story ](https://www.publicnotice.co/p/trump-saudi-nuclear-deal) Unlike inventing the next ChatGPT, actual science is slow and iterative. Government funding of research that, on its face, would not appear to lead to any big new invention is actually what underpins those big new inventions. If the government hadn’t funded research into desert lizard venom, we wouldn’t know about semaglutide, and we wouldn’t have Ozempic. If research scientists hadn’t studied how bees optimize nectar foraging within a colony, we wouldn’t have the algorithm that assigns internet traffic across computer servers. The report assiduously ignores that a symbiotic, profitable relationship between the federal government, universities, and private companies already exists. Each federal research dollar generates about $1.50 to $3.00 in long-term economic benefits. The $36 billion the government awarded in NIH research funding in fiscal year 2025 generated $94 billion in new economic activity. Trump’s proposed new golden age is intended to strip those billions from universities, resulting in the dismantling of departments and the shuttering of labs. But Katsios has a plan for that: Universities should just become trade schools to churn out no-show STEM degrees! “Require universities and community colleges to embed practical technical training and externships into STEM curricula. Let hands-on experience and industry credentials count toward degrees.” It’s quite the feat to, on the one hand, strip schools of funding for scientific research while simultaneously demanding to control what is taught and, oh, also, colleges need to give degrees to employees at big tech companies just for being employees at big tech companies. The new golden age would also exacerbate the brain drain Trump’s policies have already caused. Nature found that in the first quarter of 2025, US scientists submitted 32 percent more job applications abroad than in 2024. A March 2025 poll by Nature of roughly 1,600 scientists found that over 1,200 said they were considering leaving the country. Europe is investing $565 million to make it a “magnet for researchers” and provide funding for scientists who relocate. The new golden age is also about embedding Trump’s xenophobia into the fabric of American science. The report complains of an “over-reliance on foreign students” that “creates a security challenge our institutions are ill-equipped to address” and that a “reliance on foreign talent sidelines American students.” This is, to put it mildly, nonsense. International students pay far higher tuition and often receive no financial aid. Their tuition dollars are what make it possible for American students to get financial aid. In the 2023-2024 school year alone, international students contributed $43.8 billion to the US economy and supported over 378,000 jobs. Those 1.1 million international students accounted for only six percent of the total number of students in higher education that year, but were such an economic engine that for every three international students, one job was created or supported. It’s impossible not to wonder whether part of Trump’s loathing for universities and their leading role in scientific research is that there is no way for him to corrupt the process and make money off it in the same way he can by giving millions and billions to Silicon Valley types who, in turn, give him millions in cash. There’s no way for his children to invest in universities that the government then gives no-bid contracts to, fattening the family’s bottom line, which is pretty much the Trump sons’ current venture capital practice. Trump and Katsios’s view of science is narrow, cramped, and wrong. We’re not in a crisis, we’re not a failed state. We’ve been a science superpower for decades, and the only thing that threatens that is Donald Trump. Tech bros are already living high off the hog in this administration. They don’t need any more of our tax dollars. Hopefully this new golden age never comes to pass. Thanks for reading Public Notice. This post is public so feel free to share it. Share We’ll be back with more tomorrow. If you appreciate today’s PN, please do your part to keep us free by signing up for a paid subscription. 🚀 Subscribe to PN 🚀 Thanks for reading, and for your support.
New clues about whether genes or environment influence our health more
The bottom line is that how healthy we are isn’t solely a matter of personal choice.
Phillies host the Yankees on home losing streak
New York Yankees (59-45, second in the AL East) vs. Philadelphia Phillies (56-49, second in the NL East) Philadelphia; Sunday, 7:20 p.m. EDT PITCHING PROBABLES: Yankees: Will Warren (7-4, 4.00 ERA, 1.37 WHIP, 97 strikeouts); Phillies: Cristopher Sanchez (12-4, 2.65 ERA, 1.19 WHIP, 151 strikeouts) LINE: Phillies -175, Yankees +143; over/under is 8 runs BOTTOM LINE: The Philadelphia Phillies aim to end their four-game home losing streak with a victory over the New York Yankees. Philadelphia has a 27-27 record at home and a 56-49 record overall.
Reds try to prolong win streak, play the Cardinals
Cincinnati Reds (48-54, fifth in the NL Central) vs. St. Louis Cardinals (52-51, fourth in the NL Central) St. Louis; Saturday, 7:15 p.m. EDT PITCHING PROBABLES: Reds: Hunter Greene (2-1, 6.06 ERA, 1.16 WHIP, 26 strikeouts); Cardinals: Andre Pallante (10-6, 4.02 ERA, 1.26 WHIP, 75 strikeouts) LINE: Cardinals -150, Reds +122; over/under is 8 runs BOTTOM LINE: The Cincinnati Reds are looking to keep their three-game win streak alive when they visit the St. Louis Cardinals. St. Louis has a 26-28 record in home games and a 52-51 record overall.
AGC NYS: Data center moratorium a 'missed opportunity' for construction industry
Gov. Kathy Hochul says New York will “lead the way in creating the strongest standards in the nation for data center development,” but critics say this will hurt the Empire State’s bottom line.
Mets play the Braves looking to end road slide
New York Mets (36-53, fifth in the NL East) vs. Atlanta Braves (52-35, first in the NL East) Atlanta; Sunday, 12:30 p.m. EDT PITCHING PROBABLES: Mets: Nolan McLean (5-5, 3.78 ERA, 1.12 WHIP, 113 strikeouts); Braves: Martin Perez (6-5, 3.27 ERA, 1.16 WHIP, 61 strikeouts) LINE: Braves -198, Mets +161; over/under is 8 runs BOTTOM LINE: The New York Mets will attempt to end their three-game road slide in a matchup with the Atlanta Braves. Atlanta has a 27-16 record in home games and a 52-35 record overall.
The Best Small-Business Accounting Software
We identified the accounting software providers that add value to your bottom line.
Think Insurance Denials Only Hurt Patients? Why Business Owners Are Paying the Ultimate Price
A simple 9-week delay for a critical medication resulted in a $50,000 surgical nightmare. Here is how healthcare bureaucratic delays quietly destroy your company's bottom line.
“Bottom line, in the finals, it was kind of …
“Bottom line, in the finals, it was kind of …
Seattle visits Portland, looks to break road skid
Seattle Storm (3-12, 0-7 Western Conference) at Portland Fire (7-9, 1-5 Western Conference) Portland, Oregon; Wednesday, 10 p.m. EDT BOTTOM LINE: Seattle Storm will look to break its six-game road skid when the Storm play Portland Fire. The Fire are 1-5 against Western Conference opponents.
Family farmers squeezed by high costs, uncertainty
McBee Farm & Cattle Company rancher Steven McBee Jr. discusses how large monopolies and rising input costs are leading to challenges for family farms on ‘The Bottom Line.’
Braves look to stop slide in game against the Mets
Atlanta Braves (45-24, first in the NL East) vs. New York Mets (31-38, fifth in the NL East) New York; Saturday, 4:10 p.m. EDT PITCHING PROBABLES: Braves: Martin Perez (4-3, 3.02 ERA, 1.06 WHIP, 47 strikeouts); Mets: Sean Manaea (1-1, 5.02 ERA, 1.44 WHIP, 45 strikeouts) LINE: Mets -113, Braves -106; over/under is 8 1/2 runs BOTTOM LINE: The Atlanta Braves head into the matchup with the New York Mets as losers of three straight games. New York has gone 17-17 in home games and 31-38 overall.
Wake Forest business owners say 'Friday Night on White' concert series impacts bottom line
The monthly concert is held during the spring and summer and has become a staple in the community over the past decade.
Wake Forest business owners say 'Friday Night on White' concert series impacts bottom line
The monthly concert is held during the spring and summer and has become a staple in the community over the past decade.
Durham businesses brace for impact as water restrictions take effect
Durham's Stage 2 water restrictions start Monday, and business owners who rely on water say the impact could hit their bottom line hard.
New OMB rule could break science in the United States
The drug that saved your mother. The treatment your doctor recommended. The clinical trial that bought someone you love more time. None of it was inevitable. It required a system built to operate outside politics and sustained over decades, because science doesn’t operate on the timeline of a politician. That system is now under direct threat. The Office of Management and Budget (OMB) has proposed a new rule to regulate all federal grants, not just science, but housing, education, defense, NASA and everything in between, that would fundamentally change how research is conducted in the United States. There have been a lot of fires in the past 16 months, and if everything is an emergency, nothing is an emergency. But this is a very big deal. These rules would strip away the independence that has kept science from becoming a political tool. The good news is there’s still something we can all do. How the grant system was designed to work When I was a new faculty member, I was full of millions of ideas, so I sat down and wrote an NIH proposal. I worked on it for months and thought it was so good. Then I sent it to my mentor. It came back covered in comments. Places where my reasoning wasn’t as airtight as I’d thought, methods that could be stronger, gaps in my thinking that I had been too close to the work to see. It stung, as honest feedback always does, but peer review almost always makes the work better. In fact, it’s the backbone of how American science has functioned for generations. At NIH, submitted proposals go to a panel of scientists who have experience in the field. These are the people who can read research methods and spot their weaknesses, who understand when an experiment is designed well and when it isn’t. Applications are scored rigorously, and often only the top 3-20% of proposals receive funding. The people making funding decisions are required to justify them based on these reviews. To be clear: this is not a perfect system, and good science still goes unfunded more often than any of us would like due to limited resources. There is also criticism that peer review may undervalue bold ideas that are risky but could have high payoffs. But the peer review system is nonetheless a meaningful part of the grant selection process. While thoughtful and careful changes could improve the system, the changes being proposed by OMB will not make things better. The rule that could change everything Through this OMB proposal, the system that helps decide what gets funded is being dismantled. There are many troubling elements buried in this proposal, but three provisions stand out in particular. Each would be damaging alone. Together, they would change what kind of science gets done in America, and who it serves. 1. Political appointees would decide which science gets funded, and peer review would be explicitly sidelined or ignored. The guidelines your doctor follows, the standards that determine what’s in your air and water, the drugs that get approved for your family: all of it starts with a funding decision. Right now, that decision is made by scientists who can evaluate whether the work is actually sound and whether it could move the needle forward. Under this proposal, funding decisions could be made by political appointees. The careful, expertise-driven review process that shapes grant funding would be effectively sidelined. That means that a poorly designed study could get funded simply because someone in a political office liked the sound of it, while rigorous, important work doesn’t get funded because it no longer aligns with the administration’s priorities. In other words, critical work that benefits all of us could now be missed just because it has become politically inconvenient. 2. Grants could be canceled at any point, without warning, in the middle of ongoing work. Say your tax dollars have been paying for a cancer study for two years. The grant was awarded for five years, so the team is mid-experiment. There are three additional years’ worth of answers that could change how the disease is treated for hundreds of thousands of people. With this new rule, the federal government could cancel the remaining funding tomorrow, walk away from the commitment it made with your money, and have no legal obligation to finish what it started. This is a huge waste of money. There are rarely other sources of funding for this work, which means the team, the graduate students, postdocs, and research staff who have dedicated years of their careers to this project could lose their jobs. Patients who have contributed their time to studies may not see it turn into useful learnings for others. Every hour of work already completed could result in nothing useful. Science can take decades to get to tangible outcomes. It needs a stable funding system to flourish. 3. Researchers would have a harder time communicating their findings without pre-approval from the federal government. There is a saying from Sir Mark Walport: “Science isn’t finished until it’s communicated.” Science is no use to anyone if it is kept locked away in the labs that produced the data. The proposed rule could make communicating research findings harder in a number of ways: Make it harder for scientists to widely share their findings in scientific journals. Publication costs, including journal fees that allow for broad public access, could not be paid for by federal funds which is often how scientists pay these costs. Restrict researchers from engaging publicly about how their findings should inform policy or public health guidelines. This would restrict scientists from doing the work that transforms years of lab work into decisions that actually affect people’s lives. Make it harder for scientists to attend conferences. Conferences would now need to be approved by the federal agency at the time of grant award. This disadvantages conferences or publications that are not politically aligned. Conferences are a key way in which scientists learn about work happening in their field so they can collaborate and build on each other’s findings. What good is science with a muzzle? The long-term impact These changes could (and hopefully would) be reversed under the next administration. But by then, damage has been done. Once projects are halted or denied funding by political appointees, people leave their science careers for other paths or even leave the country to do their amazing science elsewhere. You cannot pause a scientific study the way you pause a subscription you decided isn’t useful anymore. You cannot freeze a research team that depends on salaries to feed their families, causing a scramble for replacement funding that, in most cases, simply does not exist. When the money stops, everything stops, and all the work in progress and its potential are lost. Despite all of the language about reducing waste, fraud, and abuse, this new proposed rule increases the administrative burden tremendously. Every researcher watching this unfold will make a rational decision: don’t start anything that will take a decade to finish. This includes not building a team around funding that could vanish, or asking the big questions that need patience and stability to answer. The most consequential science, the kind that produces the treatments and the breakthroughs that reach your doctor’s office twenty years from now, is exactly the science that would be abandoned first. This is still a proposal, so we can all do something Some worry this rule is already a done deal. But by law, OMB is required to open a public comment period. Those comments matter because they inform members of Congress, they can be used in litigation, and they create a public record. So here’s what you can do: Submit a public comment. The public comment period on this proposed change is open until July 13. Anyone can submit a comment, and OMB is required to respond to substantial ones. Each comment must be different to count as distinct; identical comments will be counted only once. Comment as an individual, not on behalf of your organization. Here’s a full resource to help you, with useful examples, but in general: Share a story about how science or federal funding has benefitted you or is involved in your work. Are you or someone you loved a cancer survivor? Do you know someone with Alzheimer’s? Have you received NIH/NSF or other federal funding? All of these can be stories you use to highlight why you care. Explain why you’re worried about these proposed changes. You can use the wording found here or in other resources to help you. Ask them to withdraw this proposed rule. Contact your elected representatives. Congress allocates money to federal agencies to spend, and it has oversight of how that process works. You can let your representatives know this proposed change concerns you and ask them to intervene. There are levers they can push that can help at this moment. Let others know why federal funding matters. This isn’t just about science, but ALL federal grants, including for education systems, defense projects, and more. The process, including the importance of federal funding, is invisible to many. We can all make it more visible by sharing how science benefits us and why we value it. You can also share this article, or any of the resources linked here, to help spread awareness! Bottom line We are quickly losing ground in scientific research in the U.S. More changes, like the proposed rule by OMB, would decimate our ability to conduct research here, leaving us all worse off: fewer treatments for pancreatic cancer, less research on pollution impacts, fewer answers for patients with rare disease, and more unaddressed health needs. The impact will be very real for all of us, regardless of where we stand politically. Using our voices for science is more important than ever. Love, LM Big thanks to Dr. Megan Ranney for reading this over and providing brilliant insights, as always. Dr. Liz Marnik, PhD, is Executive Director of The Evidence Collective at YLE and a science communicator and immunologist working at the intersection of public trust, science, and public health. You can find her on Substack, LinkedIn, Instagram and Threads. Your Local Epidemiologist (YLE) comprises a team of experts, ranging from physicians to immunologists to epidemiologists to nutritionists, working together with one goal: to “Translate” ever-evolving public health science so that people are well-equipped to make evidence-based decisions. The YLE suite of newsletters reaches over 475,000 people across more than 132 countries. This newsletter is free to everyone, thanks to the generous support of fellow YLE community members. To support the effort, subscribe or upgrade below: Subscribe
Orioles host the Mariners to begin 4-game series
Seattle Mariners (34-32, first in the AL West) vs. Baltimore Orioles (31-35, fourth in the AL East) Baltimore; Monday, 6:35 p.m. EDT PITCHING PROBABLES: Mariners: Emerson Hancock (4-2, 2.80 ERA, 0.95 WHIP, 70 strikeouts); Orioles: Chris Bassitt (4-4, 5.27 ERA, 1.63 WHIP, 37 strikeouts) LINE: Mariners -131, Orioles +110; over/under is 8 1/2 runs BOTTOM LINE: The Baltimore Orioles host the Seattle Mariners on Monday to begin a four-game series. Baltimore is 31-35 overall and 19-15 in home games.
Dodgers host the Angels, look to extend home win streak
Los Angeles Angels (24-41, fifth in the AL West) vs. Los Angeles Dodgers (42-23, first in the NL West) Los Angeles; Sunday, 4:10 p.m. EDT PITCHING PROBABLES: Angels: Jose Soriano (6-4, 2.72 ERA, 1.21 WHIP, 85 strikeouts); Dodgers: Emmet Sheehan (3-2, 4.50 ERA, 1.16 WHIP, 62 strikeouts) LINE: Dodgers -365, Angels +285; over/under is 8 1/2 runs BOTTOM LINE: The Los Angeles Dodgers, on a three-game home winning streak, host the Los Angeles Angels. Los Angeles has a 22-11 record in home games and a 42-23 record overall.
Schmitt leads Giants against the Cubs after 4-hit game
San Francisco Giants (26-38, fourth in the NL West) vs. Chicago Cubs (33-31, fourth in the NL Central) Chicago; Saturday, 2:20 p.m. EDT PITCHING PROBABLES: Giants: Landen Roupp (5-6, 4.22 ERA, 1.31 WHIP, 72 strikeouts); Cubs: Ben Brown (2-2, 1.92 ERA, 0.93 WHIP, 53 strikeouts) LINE: Cubs -146, Giants +122; over/under is 8 runs BOTTOM LINE: The San Francisco Giants take on the Chicago Cubs after Casey Schmitt had four hits on Friday in an 18-3 win over the Cubs. Chicago is 19-14 in home games and 33-31 overall.
New York plays Indiana after Jones' 22-point outing
Indiana Fever (5-4, 1-1 Eastern Conference) at New York Liberty (6-4, 3-0 Eastern Conference) New York; Saturday, 8 p.m. EDT BOTTOM LINE: New York Liberty faces the Indiana Fever after Jonquel Jones scored 22 points in the New York Liberty's 97-82 win against the Toronto Tempo. New York went 27-17 overall and 15-5 in Eastern Conference games last season.
Farmers turn social media videos into revenue stream to support business
Farmers Zoe Kent and Nick Welker explain how they’ve leveraged social media to generate significant income on ‘The Bottom Line.’
Why politics are now every company’s problem
Government relations can be key to boosting your company’s bottom line.
Launder Your Bottom Line with Money Fronts Bonuses
Give tourists and locals a bird’s-eye view of the Southern San Andreas scenery while taking your money laundering business to new heights with the Higgins Helitours front — available for Hands On Car Wash owners to claim for free at Maze Bank...
Ebola, chemical plants and health, hantavirus, common colds, heat and more
As they say, bugs have ears. Public health has had a relentless May. Chemical plant (near) explosions, Ebola, hantavirus, and that's before you even get to the usual suspects: common colds, heat, and ticks. Here’s an attempt to keep you up to speed and, more importantly, what it means for you and your community. But first, an announcement: World Cup The World Cup starts in 15 days (not like anyone is counting down), and we are hanging TVs in the Health Security Operations Center. It’s going to be a gorgeous, chaotic celebration of basically every culture on earth. And it’s going to take a team effort—from communities to individuals, from public health to health care—to keep people healthy. That’s where you come in. If you’re going to the games or live within 30 miles of a stadium, we would love to hear from you. Sign up for a weekly survey here. Thanks to the more than 1,280 people who have already signed up…you will be hearing from us soon!! Global disease “weather report” Hantavirus: Two more cases The global count of cruise ship passengers with hantavirus has now increased to 13 cases (11 confirmed), with three deaths. The two new cases are overseas and among people who were already quarantining: A crew member in the Netherlands. A Spanish national passenger who was quarantining at home tested positive through daily monitoring. They are now in a biocontainment unit. In the U.S., everyone remains negative. There may be more cases, given that the incubation period of hantavirus (the time from exposure to infection) is 45 days. But this week, we will reach a major milestone: the median incubation window is 18 days, and that will pass on May 29. What this means for you: Your risk from this cruise ship outbreak remains essentially nil at this point. Ebola rages on in Central Africa Big thanks to Dr. Craig Spencer, a humanitarian physician who has treated and survived Ebola, for jumping in to provide the YLE community with an update. Craig, take it from here… The combined confirmed and suspected Ebola cases in DRC are now more than 1,000. All signs are pointing to a very long and catastrophic outbreak in Central Africa: This is a vast undercount. We know this because the test positivity rate is hovering around 50%, only 20% of contacts are being traced (and in some areas, no contacts at all), and more cases keep popping up with no known connection. This all points to widespread and undetected community transmission. This is in only a week of detection. Compared to previous outbreaks, the growth is very fast, as the huge West Africa outbreak in 2016 was first detected at 49 cases and rose to 208 cases a month later. It took four months for that outbreak to reach the size of the current one in the DR Congo. The cases are spread out across 16 health zones. There are now multiple epicenters, making containment very difficult. Next door in Uganda, the case count is seven. While this number is low compared to DRC, a concerning development is that two health care workers recently tested positive with uncertain exposure histories. If they weren’t treating known Ebola cases, this means it’s spreading undetected in Uganda as well. On the ground, backlash, including the burning of health centers, has emerged, a pattern seen in nearly every outbreak and rooted in deep community distrust. It often stems from outside actors working in communities without fully understanding or addressing local priorities. Affected populations may recognize the severity of Ebola while still holding other concerns as more pressing, such as where their loved ones are buried. Community trust is essential to an effective response, but difficult to build during an active emergency. It is best established long before a crisis begins. U.S. priorities are made clear, and may backfire. The U.S. Administration has shown that its first priority is keeping Ebola out, with helping end the outbreak in the DRC a secondary concern. That's meant travel restrictions broader than anything we've imposed before — covering travelers from across the region, and reportedly some green card holders and permanent residents as well. For example, just these past two days, news broke that high-risk American travelers will be subject to a mandatory quarantine in Kenya before they are allowed to return. If an American is infected, the U.S. government plans to send them to a hospital it is standing up from scratch in Kenya. (Currently, Americans who were in the area are allowed to return but are diverted to three airports—Houston, Atlanta, and DC—for further screening.) Past administrations have used travel notices and stepped-up screening; this goes much further. At first blush, these strict precautions may sound prudent. But this approach could backfire in three ways: Restrictions this blunt give people every reason to hide where they’ve been and whom they’ve been near — making the people we most need to find harder to track, not easier. They also breed a false sense that this is someone else’s problem. But diseases are humbling. They find the small cracks in even the most impenetrable-seeming defenses. Lives lost. There is no treatment for this Ebola strain, which means survival depends heavily on the quality of the health system. We have that system in the States, but we are choosing not to use it for infected Americans. This is unbelievable and infuriating. (See a deeper dive from me here.) The only real way to lower the risk to Americans — and everyone else — is to end the outbreak in the DRC and across the region. What this means for you: If you have travel plans to this region, it’s time to cancel them. This is a high-risk situation in Central Africa, and CDC released a Level 4 Travel Advisory. There is also great uncertainty if and when the Administration will let you back in. To the general public in the U.S., your risk remains very, very low right now. U.S. disease “weather report” Ticks: past peak season? Good news, especially for people in the Northeast and Midwest: tick numbers continue to decline. Though we are at the peak of the season, this unusually early year is trending favorably. Heat-related illnesses in the North Heat risk is certainly not blanketing the entire country yet, but this week it will be moderate in the Midwest and the Southeast. What this means for you: Be sure to check the CDC HeatRisk tool. A red day isn’t the best day for that soccer game for a kid with asthma, and a stretch of orange days is a great time to check on your elderly neighbor. Common colds surging As far as respiratory viruses go, the only thing really going around right now is the common cold. It is higher this year than last year, but should peak very soon before returning this fall. Spotlight: Chemical plants Over the weekend, YLE California covered the serious situation that unfolded around a chemical plant in Orange County, California. Thankfully, the worst-case scenario (a chemical explosion) was mitigated, but only through luck. The health implications in a densely populated area could have been catastrophic. As the situation was winding down, another chemical explosion struck Washington State. This one was fatal. Health officials say the risk to surrounding residents from chemicals in the air and ground remains low, though the community deserves far greater clarity. Clean air and clean water consistently rank as Americans’ top public health concerns — yet when chemical disasters strike, communities are too often met with reassurances rather than transparency and accountability. Residents near the 2023 East Palestine, Ohio train derailment, for example, are still waiting to understand the long-term impact on their health, with few clear answers. What this means for you: Many are wondering if facilities processing potentially dangerous materials are in their neighborhoods. This interactive map allows you to enter your ZIP code and see all facilities monitored by the EPA, including any violations. Good news Ebola vaccines and treatment for the Bundibugyo species are in development. Two vaccine platforms are being explored, at least one of which may be deployable in as little as 2 months. One vaccine is being developed by Oxford, and the other uses the same biotechnology as the FDA-approved Zaire species of Ebola. (It may provide cross-protection, but it’s unclear at this point.) On the treatment side, two promising monoclonal antibody cocktails are likely to be deployed, though doses are limited and logistical hurdles remain significant challenges. Anni over at The Biotech Tea had a great explainer about the Ebola vaccine gap, if you want to read more. [ The Biotech Tea The Ebola vaccine gap, reading vessel damage, & the Makary exit 🗝️ Paid subscribers get the Biotech Term of the Week at $30/year (~$2.50/month). I try to keep it intentionally accessible, but if cost is ever a barrier, send me a message. A few people asked about expensing your subscription, so I put together a short email template… Read more 6 days ago · 10 likes · Annicka Evans, PhD ](https://www.thebiotechtea.com/p/the-ebola-vaccine-gap-reading-vessel?utm_source=substack&utm_campaign=post_embed&utm_medium=web) Polycystic ovary syndrome (PCOS) has been officially renamed polyendocrine metabolic ovarian syndrome (PMOS), following more than a decade of debate and input from roughly 22,000 clinicians, researchers, and patients worldwide. This is good because the old name was medically misleading, leading to patients without visible cysts being dismissed or overlooked entirely. The WHO estimates that 70% of people with the condition remain undiagnosed. A more accurate name should improve recognition, reduce stigma, and ultimately help the millions of people living with this condition get diagnosed and treated sooner. Poll Loading... Bottom line Public health situations are everywhere right now. Staying healthy takes public health professionals and systems working tirelessly behind the scenes and each of us showing up for our neighbors and communities. Love, YLE Big thanks to Ed Nirenberg for staying on top of the Ebola vaccines, Hannah Totte for all the figures, Dr. Craig Spencer for the Ebola insight, and Dr. Matt Willis for covering the chemical situation in CA. Your Local Epidemiologist (YLE) comprises a team of experts, ranging from physicians to immunologists to epidemiologists to nutritionists, working together with one goal: to “Translate” ever-evolving public health science so that people are well-equipped to make evidence-based decisions. YLE suite of newsletters reaches over 475,000 people across more than 132 countries. This newsletter is free to everyone, thanks to the generous support of fellow YLE community members. To support the effort, subscribe or upgrade below: Subscribe
Miraval Austin: Bottom Line Review
Miraval is Hyatt’s “wellness” brand, with three locations in the US and one in the Middle East. Each property has an extensive array of classes, ranging from pilates to yoga, axe-throwing to tarot card reading. Most of them are included in the room rate, whether booking with cash or points, as is all food and […]
The Enhanced Games is here. But forget the ‘sport’ – it has something it wants to sell you
A competition where drug taking is legal may appeal and intrigue in equal measure, but the bottom line is what counts
Minnesota politicians restarted fraudulent program due to political pressure, Rep Jim Jordan says
Rep. Jim Jordan, R-Ohio, praises the DOJ’s charges against individuals tied to alleged Minnesota fraud schemes on ‘The Bottom Line.’
Royals look to end slide in matchup with the Cardinals
Kansas City Royals (19-26, fifth in the AL Central) vs. St. Louis Cardinals (26-18, third in the NL Central) St. Louis; Saturday, 2:15 p.m. EDT PITCHING PROBABLES: Royals: Noah Cameron (2-2, 5.55 ERA, 1.63 WHIP, 32 strikeouts); Cardinals: Kyle Leahy (4-3, 4.31 ERA, 1.59 WHIP, 32 strikeouts) LINE: Royals -112, Cardinals -106; over/under is 8 1/2 runs BOTTOM LINE: The Kansas City Royals aim to end a five-game slide with a victory over the St. Louis Cardinals. St. Louis has an 11-10 record in home games and a 26-18 record overall.
Atlanta Beltline violence: Shops report booming business despite incidents
Business owners in the Old Fourth Ward report that crime has not hurt their bottom line and sales are up.
NYC business owners oppose Mamdani’s city-run grocery stores: ‘It’s a concern’
Multicultural Business Coalition chairman Frank Garcia assesses New York City Mayor Zohran Mamdani’s plan to open city-owned grocery stores on ‘The Bottom Line.’
Business owner leaves Washington after 48 years
Delta Camshaft owner Jon Bodwell reveals what led to leave the state on 'The Bottom Line.'
Oak Park restauranter says water, sewer pipe construction near business is biting into his bottom line
Political expert slams Bernie Sanders proposed ‘data center moratorium’ bill under guise of AI safety
Government Accountability Institute executive director Seamus Bruner analyzes Sen. Bernie Sanders’, I-Vt., artificial intelligence criticisms on ‘The Bottom Line.’
Touring Entertainment Live Report 2026
Now in its third year, the sold-out Touring Entertainment LIVE (TEL) brought show producers, promoters, and experts from analytics companies, tech platforms, PR agencies, venues, and ticketing agencies together in London in February to discuss the current state of touring entertainment. The conference featured sessions that discussed how to boost the bottom line against increasing […]
Carolina visits Philadelphia with 3-0 series lead
Carolina Hurricanes (53-22-7, in the Metropolitan Division) vs. Philadelphia Flyers (43-27-12, in the Metropolitan Division) Philadelphia; Saturday, 6 p.m. EDT LINE: Hurricanes -188, Flyers +156; over/under is 5.5 NHL PLAYOFFS SECOND ROUND: Hurricanes lead series 3-0 BOTTOM LINE: The Carolina Hurricanes visit the Philadelphia Flyers in the second round of the NHL Playoffs with a 3-0 lead in the series. The teams meet Thursday for the eighth time this season.
Brewers host the Yankees to start 3-game series
New York Yankees (26-12, first in the AL East) vs. Milwaukee Brewers (19-16, fourth in the NL Central) Milwaukee; Friday, 7:40 p.m. EDT PITCHING PROBABLES: Yankees: Max Fried (4-1, 2.39 ERA, 0.89 WHIP, 43 strikeouts); Brewers: Jacob Misiorowski (2-2, 2.84 ERA, 1.00 WHIP, 59 strikeouts) LINE: Yankees -139, Brewers +117; over/under is 7 runs BOTTOM LINE: The Milwaukee Brewers host the New York Yankees on Friday to open a three-game series. Milwaukee has a 19-16 record overall and a 10-8 record at home.
Astros visit the Reds to start 3-game series
Houston Astros (15-23, fifth in the AL West) vs. Cincinnati Reds (20-18, fifth in the NL Central) Cincinnati; Friday, 6:10 p.m. EDT PITCHING PROBABLES: Astros: Mike Burrows (1-4, 5.97 ERA, 1.65 WHIP, 36 strikeouts); Reds: Nick Lodolo (0-0) LINE: Reds -136, Astros +114; over/under is 9 1/2 runs BOTTOM LINE: The Cincinnati Reds host the Houston Astros on Friday to open a three-game series. Cincinnati is 20-18 overall and 10-8 in home games.
Why Live Nation Entertainment Stock Jumped 7% Today
A $450 million legal charge crushed Live Nation's bottom line. So why did the stock jump 7% on the news?
Cardinals start 3-game series with the Brewers
Milwaukee Brewers (18-15, fourth in the NL Central) vs. St. Louis Cardinals (20-14, third in the NL Central) St. Louis; Monday, 7:45 p.m. EDT PITCHING PROBABLES: Brewers: Chad Patrick (2-1, 2.57 ERA, 1.25 WHIP, 16 strikeouts); Cardinals: Kyle Leahy (3-3, 5.52 ERA, 1.67 WHIP, 22 strikeouts) LINE: Brewers -115, Cardinals -105; over/under is 8 1/2 runs BOTTOM LINE: The St. Louis Cardinals host the Milwaukee Brewers to start a three-game series. St. Louis is 20-14 overall and 9-9 at home.
Celtics, 76ers set for winner-take-all game 7
Philadelphia 76ers (45-37, seventh in the Eastern Conference) vs. Boston Celtics (56-26, second in the Eastern Conference) Boston; Saturday, 7:30 p.m. EDT LINE: Celtics -7.5; over/under is 205.5 EASTERN CONFERENCE FIRST ROUND: Series tied 3-3 BOTTOM LINE: The Boston Celtics and the Philadelphia 76ers square off in game seven of the Eastern Conference first round. The 76ers defeated the Celtics 106-93 in the last matchup on Friday.
Samsung may be bracing for first-ever annual loss in smartphone business
The AI-driven memory shortage is hitting Samsung's bottom line.
Samsung may be bracing for first-ever annual loss in smartphone business
The AI-driven memory shortage is hitting Samsung's bottom line.
Business owner says her furniture company thrives due to a community of collaborators
‘Made in America’ finalists Tina Nicole and Khai Mai describe how they created Nathan Anthony Furniture on ‘The Bottom Line.’
Working family tax cuts 'absolutely vital' to small businesses across US, Kelly Loeffler says
Small Business Administration administrator Kelly Loeffler and Jimmy's Famous Seafood co-founder Tony Minadakis discuss the benefits of the new Trump tax law for small businesses on 'The Bottom Line.'
PGA Sustainability Toolkit Launches With Focus on Bottom Line
The trade group’s latest green production resource offers advice for cutting down emissions on set — and selling that approach to top creatives and heads of department.
Pulse of Politics: Dealing with inflation & Michigan Gubernatorial Debates
Financial Instructor Michael Masserant with the Retirement Education Foundation discusses how we can help our bottom line amid inflation and economic concerns. Plus, Pulse Anchor Roop Raj and Pulse of Politics Host Aaron Jordan discuss the upcoming Michigan Gubernatorial Debates, hosted by FOX 2.
FOX Business’ ‘Made in America’ contest features veteran-owned cycling business
Pedal Guerrero owner Joe Leon discusses his business and journey to becoming a ‘Made in America’ finalist on ‘The Bottom Line.’
FOX Business’ ‘Made in America’ contest features Steele Saddle Tree
Steele Saddle Tree’s Ed Steele and Allen Holloway discuss their business and journey to becoming ‘Made in America’ finalists on ‘The Bottom Line.’
Tips on how to handle politics in the workplace in Iowa
The bottom line: Iowa’s private employers have wide latitude to regulate political activity at work.
‘I don’t see any new faces’: Rochester Road construction changes daily life for small businesses in Troy
Some businesses along Rochester Road in Troy say ongoing roadwork is cutting into their bottom line.
I Was Shocked to See How Much This Fast-Growing Business Is Adding to Walmart's Bottom Line
Even at less than 1% of fiscal year 2026 sales, this is already a game changer for the business and the stock.
I Was Shocked to See How Much This Fast-Growing Business Is Adding to Walmart's Bottom Line
Even at less than 1% of fiscal year 2026 sales, this is already a game changer for the business and the stock.
United Airlines splits business class into tiers on long-haul flights
The airline industry is looking for new revenue lines to bolster the bottom line amid stiff economic headwinds.
Columbus is betting big on women's sports — and the payoff is already here
Columbus is going all in on women's sports — and the city's bottom line is already feeling it.
Democrats want to ‘weaponize the political system’ against their opponents: Former Trump campaign advisor
‘My View with Lara Trump’ host Lara Trump and former Trump campaign senior advisor Jason Miller discuss ‘No Kings’ anti-Trump protests across the U.S. on ‘The Bottom Line.’
Kaiser made $9.3 billion last year. Critics say it has strayed from its charitable mission
Kaiser Permanente, the nation's largest non-profit health group, has veered from its charitable mission and is now scarcely distinguishable from a corporation keenly focused on its bottom line, according to critics.
Stars visit the Flyers after Bourque's 2-goal performance
Dallas Stars (44-18-11, in the Central Division) vs. Philadelphia Flyers (36-24-12, in the Metropolitan Division) Philadelphia; Sunday, 7 p.m. EDT BETMGM SPORTSBOOK LINE: Stars -154, Flyers +129; over/under is 5.5 BOTTOM LINE: The Dallas Stars visit the Philadelphia Flyers after Mavrik Bourque's two-goal game against the Pittsburgh Penguins in the Stars' 6-3 win. Philadelphia has a 16-12-8 record at home and a 36-24-12 record overall.
Health-Care Costs Are Forcing Terrible Trade-Offs
Earlier this month, as I waited to pick up a prescription at my local CVS, I watched a man leave without his elderly father’s medication. The pharmacist had tried several tricks to lower the cost. It wasn’t enough. When the man heard the bottom line, he stuffed his hands in his pockets and, after a long, awkward silence, walked away.
Glyphosate: A story of science, risk, and nuance
In the summer of 2014, a California groundskeeper named Dewayne Johnson started noticing patches of raw, weeping skin spreading across his body. He had spent years applying Roundup, Monsanto’s glyphosate-based herbicide, for a school district, sometimes drenched in it when equipment malfunctioned. By 2014, he had a diagnosis: non-Hodgkin’s lymphoma. In 2018, a jury awarded him $289 million in damages, later reduced on appeal. Tens of thousands of lawsuits followed. The story hasn’t quieted down. It’s all over the internet, swinging between “this will kill you, buy organic” and “relax, you’re fear-mongering.” Some of that recent chatter stems from an Executive Order protecting glyphosate and its production, which set off intense infighting within the MAHA movement. Some of it reflects a deeper truth: Americans genuinely care about harmful chemicals in their environment (see poll below). And the conversation isn’t going anywhere, with a Supreme Court case involving Monsanto set for this April. Glyphosate (the active ingredient in Roundup) is one of the most widely used herbicides in the world. But does glyphosate cause cancer? And how much exposure is actually risky? With so much mistrust in institutions and corporations (and some genuine conflicts of interest), making sense of the actual scientific evidence is genuinely hard. Here is a translation of what the scientific evidence actually says. Does glyphosate cause harm? Glyphosate is an herbicide that kills most plants it contacts rather than targeting specific species. It works by blocking an enzyme pathway (EPSPS) that plants and many microorganisms need to produce essential amino acids. Without those amino acids, the plant can’t grow and dies. Glyphosate was first developed by Monsanto in the 1970s and became ubiquitous after the company introduced “Roundup Ready” crops in the 1990s. In 2024, Bayer removed glyphosate from residential Roundup-branded products due to litigation pressure. But today it is still the most widely used herbicide in the world. Farmers also discovered they could spray it directly on crops like oats, lentils, beans, and peas just before harvest to dry them out faster and make harvesting easier. Because of its widespread use, it’s obviously really important to understand if it’s harmful to humans. The key principle: The dose makes the poison The most important concept in toxicology is that “the dose makes the poison.” Sixteenth-century physician Paracelsus articulated what remains the foundational principle of toxicology: sola dosis facit venenum. Water will kill you if you drink enough of it. Aspirin saves lives at 81 milligrams and causes internal bleeding at higher chronic doses. So, at what dose is glyphosate poisonous? The LD50 in rats (the dose that kills half the test animals) is around 5,600 mg/kg body weight. Table salt is roughly 3,000 mg/kg. By that classic measure, glyphosate is less acutely toxic than salt. But some people are exposed to a lot of glyphosate through their work. And among the general public, there are many questions about low-dose, cumulative exposure from multiple sources over long periods. Does glyphosate cause health problems? Cancer Correlation maps are striking, with one analysis finding that 60% of counties that spray the most glyphosate have non-Hodgkin’s lymphoma rates above the national average. But correlation alone doesn’t establish cause, which is why animal and human studies matter. In animals: Rat studies are typically what most fear is rooted in, but most people don’t know the study details on the dosage given to rats. A pooled analysis of the 13 most rigorous rat studies found evidence that very high doses, around 55,000 times greater than typical food residue exposure, can cause certain cancers. In humans: One of the strongest studies followed 55,000 herbicide users over 20 years and found no overall increased cancer risk. There was one signal: among those with the highest use, rates of acute myeloid leukemia (AML) appeared elevated. A broader meta-analysis of 18 human studies also found no overall cancer risk, though a separate meta-analysis focused specifically on non-Hodgkin lymphoma found that people with high cumulative glyphosate exposure faced a 41% higher relative risk compared to those with low or no exposure. These human studies are observational studies (randomized controlled trials would be unethical), and meta-analyses are only as reliable as the studies they pool. But the story seems consistent: at very high exposure levels, there may be some cancer risk. But that’s about as far as the science currently takes us. Emerging research: gut and reproductive health Gut: Because glyphosate targets a pathway that exists in some gut bacteria, scientists have questioned whether it could affect the microbiome. In mice, a 2023 University of Iowa study found that glyphosate altered gut bacterial composition and raised markers of intestinal inflammation. A 2024 systematic review found similar patterns: disrupted gut bacteria and problems with the mucus layer that protects the intestinal wall in mice. Whether this translates to humans is an open question. The human gut is highly variable and resistant, and we don't yet have strong studies confirming the same effects in people. Reproductive health: Animal studies have found that glyphosate-based herbicides can interfere with reproductive hormones, including disrupting egg cell development in mice and reducing the number of eggs available in sheep’s ovaries. However, the doses used in these experiments were high, so it’s not yet clear whether the same effects would occur in humans. On the human side, a 2021 pilot study led by Mount Sinai researchers tested urine samples from pregnant women across the U.S. and found glyphosate in 95% of them. The study also found a possible connection between higher glyphosate exposure during pregnancy and a subtle physical difference measured in female newborns. That said, some connections weren’t statistically reliable and this was a small study. The researchers themselves said more and larger studies are needed before drawing firm conclusions. What do regulators say about glyphosate safety? In 2015, the International Agency for Research on Cancer (IARC), part of the World Health Organization, classified glyphosate as "probably carcinogenic to humans" (Group 2A). The classification is worth taking seriously. But, there’s an important distinction: IARC classifies hazard, meaning the potential to cause harm under some conditions. It does not assess risk, which accounts for actual exposure levels and the real-world probability of harm. The U.S. EPA, the European Food Safety Authority, Health Canada, and regulatory agencies in Australia and Japan have all concluded that glyphosate is “unlikely to be carcinogenic to humans” at realistic exposure levels. They’re asking a different question: given how much of this people actually encounter, what is the probability of harm? Your actual exposure is what determines your actual risk. What does glyphosate mean for your daily life? At the grocery store: Food residues are small. The EPA’s acceptable daily intake is 1.75 mg/kg of body weight per day. To hit that threshold from oatmeal alone, a 150-pound adult would need to eat roughly 50 pounds of oats every day. But this calculation addresses only one pathway (food), and we don’t yet have robust tools to measure people’s actual total exposure. If reducing exposure matters to you, organic certification prohibits synthetic herbicides, and organic oat products generally test at lower or undetectable levels. Either way, a diet rich in whole grains, conventional or organic, is far better for your health than one that omits them out of fear of residues. On the farm: Occupational exposure is orders of magnitude higher than consumer exposure. Farmers and farm workers who mix, load, and apply glyphosate-based herbicides, especially without protective equipment, face meaningfully different risk profiles. Proper PPE isn’t optional. Integrated weed management strategies that rotate chemical modes of action are also worth taking seriously, both for health and for long-term effectiveness. If you live near a farm: Spray drift is real. Concentrations near field edges can spike during and after application, particularly on windy days. This is an area where I think public health could really step up and empower rural communities with buffer zones, rather than placing the onus on individuals. But for now, knowing your local agricultural calendar and keeping windows closed during application are the first steps. Bottom line Dewayne Johnson was exposed to glyphosate at levels most people will never encounter, and a jury decided he deserved compensation. That outcome is not evidence that the oatmeal in your pantry is dangerous. But it is a reminder that the dose, the context, and the person doing the exposing all matter enormously. Glyphosate is a chemical tool with benefits, trade-offs, and genuine open scientific questions. Learning to hold that complexity without collapsing into panic or dismissal is, honestly, one of the most useful and hardest things to do in navigating modern health science. Love, YLE Your Local Epidemiologist (YLE) is founded and operated by Dr. Katelyn Jetelina, MPH PhD—an epidemiologist, wife, and mom of two little girls. Hannah Totte, MPH, is an epidemiologist and YLE Community Manager. YLE reaches more than 425,000 people in over 132 countries with one goal: “Translate” the ever-evolving public health science so that people will be well-equipped to make evidence-based decisions. This newsletter is free to everyone, thanks to the generous support of fellow YLE community members. To support the effort, subscribe or upgrade below: Subscribe
Why the BTS Comeback Concert Was a ‘Disaster’ for Some Businesses
The turnout for the K-pop titans’ show was much lower than projected by officials, hitting the bottom line of some restaurants. Shares in the group’s management company also fell.
Steve Hilton: The business model in California ‘depends on fraud’
California GOP gubernatorial candidate Steve Hilton says he will be the ‘exact opposite’ of Gov. Gavin Newsom in his approach to fraud allegations on ‘The Bottom Line.’
One big question: how have increased energy costs affected your business?
For this week's One Big Question feature, we ask business leaders how increasing fuel and energy costs have been affecting their bottom lines.
Linux Finally Catches Up to Windows with a Game-Changing Performance Feature
For years, the Linux kernel’s scheduler has been world‑class at balancing loads, yet it missed a crucial, cache‑aware instinct. In modern multi‑core systems, that gap can turn into measurable latency, especially when threads bounce between cores that don’t share the same cache. A new upstream feature, often called Cache Aware Scheduling, is now set to change that equation. A cache‑savvy scheduler arrives At the heart of any OS, the scheduler decides which thread runs where and for how long. In modern CPUs, small private caches (L1 and L2) sit beside each core, while a larger Last Level Cache (LLC, typically L3) is shared among groups of cores. When a task migrates across LLC boundaries, its warm data may vanish from the cache, forcing slower trips to main memory. Cache Aware Scheduling keeps related tasks close to their shared LLC, reducing destructive migrations. By respecting cache topology, the kernel minimizes cold‑start penalties and preserves locality that many workloads desperately need. The result is less thrashing, fewer memory stalls, and more consistent throughput. "Keep tasks close to their data, and the system will keep performance close to its peak." Why this narrows the Windows gap Windows has long leaned on topology‑aware, cache‑sensitive heuristics, especially since the Windows 10 era. That advantage helped Microsoft handle hybrid designs with P‑cores and E‑cores, plus complex cluster and NUMA layouts. With cache awareness integrated upstream, Linux brings parity to this vital dimension, without sacrificing its trademark flexibility. The Linux approach remains deeply configurable, reflecting the ecosystem’s breadth across servers, desktops, and embedded devices. It layers atop existing NUMA‑balancing and energy‑aware logic, refining placement rather than reinventing the wheel. Crucially, it aligns scheduling with the hardware’s real shape, not just with abstract CPU counts. Real‑world gains and who benefits Early tests on Intel Sapphire Rapids platforms point to gains in the 30–45% range for select workloads. Those wins appear in cache‑sensitive tasks like in‑memory analytics, high‑thread compilation, and microservices with tight working‑sets. Games and latency‑bound engines can also feel steadier frame‑times, especially when threads share hot assets. The benefits extend to AMD’s 3D V‑Cache parts, where keeping threads near enlarged cache slices prevents needless misses. Hybrid x86 designs with performance and efficiency cores further profit when cache and core roles are scheduled in concert. Even handhelds running SteamOS can squeeze more out of limited power, translating cache locality into smoother play. Key advantages include: Lower end‑to‑end latency Fewer expensive misses to RAM Better multi‑socket and NUMA behavior Improved energy efficiency More predictable QoS under mixed loads Stronger scaling on dense servers Caveats, tuning, and rollout No scheduler change is purely free, and trade‑offs still exist. Favoring locality can reduce cross‑cluster balance if limits are set too tight. Likewise, fairness and utilization must remain healthy, especially under heterogeneous, bursty workloads. Linux’s implementation is designed to be measured and tunable, not a blunt instrument. It cooperates with energy‑aware scheduling for mobile efficiency, and with NUMA‑balancers on big iron. Expect architecture‑specific refinements as vendors surface richer topology hints and cache‑sharing maps. Upstream integration has begun, with broad distribution adoption likely over the next cycles. Many users will encounter the change through standard kernel updates in 2025–2026, depending on distro cadence. Server‑class kernels may enable or tune it sooner for targeted fleets where cache locality is money in the bank. How to think about performance impact Cache Aware Scheduling amplifies gains when your workload is both CPU‑bound and cache‑sensitive. Think tight inner loops, hot code paths, and datasets that fit snugly in shared LLC. It’s less dramatic for I/O‑bound services or memory‑hungry tasks that blow past cache capacity. Still, even modest locality improvements often translate into smoother tail‑latency, which is where user experience and SLAs typically break. Developers can further help by pinning related threads, batching work, and aligning data to reduce cross‑cluster chatter. The scheduler’s new awareness works best when applications expose good hints. The bottom line By understanding and honoring cache topology, Linux removes a subtle yet costly bottleneck. The kernel’s smarter placement keeps hot data hot and work near where it belongs. That narrows a long‑standing gap with Windows, while preserving the openness and tunability Linux champions. For gamers, creators, and operators, the payoff is practical: more consistent frames, faster builds, and snappier services. For the ecosystem, it’s another step toward hardware‑savvy scheduling that turns transistor complexity into real‑world speed. And for Linux itself, it’s a timely upgrade that matches today’s silicon with tomorrow’s expectations.
Small Business
This brand-new documentary series takes viewers inside small businesses to break down what they earn, what they spend, how they grow, and what it takes to stay profitable. We explore everything from payroll to marketing—all told through the voice of the business owner, as they show us the systems, challenges, and decisions that shape their bottom line.
Local business owners say profits take a hard hit when crime happens nearby
A Durham restaurant is closed after a deadly shooting, and so are nearby businesses. Some owners and government officials say the violent crime not only impacts the people targeted, but also the local businesses' bottom line.
'We can only hope': Local business owners say violent crime is hurting bottom lines
A Thursday night shooting, killing a pizza shop employee, shut down a shopping center for hours, forcing other businesses to close and miss out on profits. City leaders say violent crime not only impacts its target, but also the local economy.
FCC probes sports streaming deals amid rising consumer costs
FOX Business correspondent Darren Botelho reports on the FCC’s probe into sports streaming deals and whether they are driving up costs and limiting access for consumers on 'The Bottom Line.'
In earnings call, Hims CEO addresses scrutiny of GLP-1 compounding
In earnings call, Hims & Hers CEO Andrew Dudum addressed the increased scrutiny on compounded GLP-1s and its impact on the business’s bottom line.
How tariffs have impacted NYC small business bottom line
North Carolina small business owners on how tariffs are negatively impacting their bottom line
Many of the gifts that define Valentine’s, especially flowers and chocolates, rely heavily on imports which have been affected by tariffs.
Voter ID is an ‘existential political issue’: Rep Brandon Gill
DEK: Rep. Brandon Gill, R-Texas, explains why he thinks the SAVE America Act is ‘common sense’ legislation on ‘The Bottom Line.’
This is the type of politics Americans ‘HATE’: Florida lawmaker
Rep. Anna Paulina Luna, R-Fla., discusses a contentious congressional immigration hearing where Democrats strongly criticized I.C.E. on ‘The Bottom Line.’
Government shutdown or ICE accountability? Senator says that's 'bottom line'
On the verge of another government shutdown, California Sen. Alex Padilla wants more accountability for ICE and less funding for Homeland Security.
UT Martin visits Western Illinois following Nicastro's 27-point game
UT Martin Skyhawks (11-8, 7-3 OVC) at Western Illinois Leathernecks (17-3, 9-2 OVC) Macomb, Illinois; Saturday, 2 p.m. EST BOTTOM LINE: Western Illinois takes on UT Martin after Mia Nicastro scored 27 points in Western Illinois' 69-55 win over the Southeast Missouri State Redhawks. The Leathernecks are 10-0 on their home court.